SR One
CVC🇺🇸 United StatesInvestment thesis
Trans-Atlantic biotech VC using a 'back-and-build' approach: backs companies with strong fundamentals and a clearly defined development pathway, providing both financial and operational support. For platforms, requires a clear thesis on why the modality can deliver clinical benefit.
Notable portfolio
AdaptimmuneAlector
Sector focus
BiotechTherapeutics